NasdaqCM - Nasdaq Real Time Price USD
BriaCell Therapeutics Corp. (BCTXW)
0.1522
+0.0272
+(22.10%)
As of 10:41:58 AM EDT. Market Open.
Breakdown
TTM
7/31/2024
7/31/2023
7/31/2022
7/31/2021
Operating Cash Flow
-21,994.8620
-24,126.1280
-23,744.8600
-12,484.3760
-7,750.1880
Investing Cash Flow
-831.8010
-681.8010
--
--
--
Financing Cash Flow
21,595.7890
4,418.9260
3,954.3000
-3,742.6570
64,997.6240
End Cash Position
5,013.6540
862.0890
21,251.0920
41,041.6520
57,268.6850
Capital Expenditure
--
-456.8010
--
--
--
Issuance of Capital Stock
20,774.7740
4,418.9260
4,000
--
51,622.3370
Issuance of Debt
--
--
--
--
215.7100
Repayment of Debt
--
--
--
--
-546.1080
Repurchase of Capital Stock
--
--
-47.2940
-10,171.7320
--
Free Cash Flow
-22,451.6630
-24,582.9290
-23,744.8600
-12,484.3760
-7,750.1880
-
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
RNTX Rein Therapeutics Inc.
1.8550
+1.92%
IPHA Innate Pharma S.A.
2.0000
+1.52%
IBOGF Universal Ibogaine Inc.
0.0177
-7.30%
T3X.F Telix Pharmaceuticals Limited
15.90
+0.63%
388870.KQ Pharos iBio Co., Ltd.
6,980.00
-3.06%
KTTAW Pasithea Therapeutics Corp.
0.0178
+7.88%
ADAG Adagene Inc.
1.5094
+5.55%
AAPG Ascentage Pharma Group Internat
25.50
+6.69%
GLMD Galmed Pharmaceuticals Ltd.
1.6307
+0.04%
LEXX Lexaria Bioscience Corp.
1.5715
-1.16%